We are delighted to announce that Mtech Access are now a certified NICE Medtech Early Technical Assessment (META) Tool facilitating organisation. Samantha Gillard (Director – HTA), Persefoni Ioannou (Consultant –...
Read More
What is the EU Joint Clinical Assessment (JCA) and what does it mean for market access and reimbursment in Euorpe?
We are delighted to announce that the second edition of our popular introductory guide: ‘Market access and reimbursement in key European markets’ is now available. Our market access experts have...
Read More
We’re delighted to announce that we will be exhibiting at ISPOR Europe in Copenhagen over the 13th–15th November 2023. Visit our virtual booth Meet the team Research & Posters Meet...
Read More
What is IDAP? As the IDAP pilot opens, we explore how this new pathway offers a fast-track route to patient access for innovative medical technologies.
Maria Dimitrova shares her career journey from public sector roles working with the SMC and SHTC to joining Mtech Access as a Consultant supporting our Pharma and Medtech clients with HTA submissions.
What is an AMCP dossier and how are they used in US market access? Drawing on their extensive experience compiling AMCP dossiers, here, our global market access experts explain when, why and how…
How can you ensure that the market access materials, value proposition and evidence developed by global teams, will resonate for your local audience? In this article, our experts pool their knowledge to share their top tips for successfully taking global materials local.
We explore some of the key themes o the agenda for The MedTech Forum from MDR to Digital Twins
Helen Lilley tells us about her experiences and activities as a medical writer at Mtech Access, supporting projects from local communication materials to global value dossiers to HTA submissions.
